Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
The message from our plaintiffs' lawyer colleagues has been steady and direct: “Don't bother defending these cases ' you're going to lose and you're going to lose big. Just pay us all lots of money now and save yourself a lot of pain and agony.” And what other message would they send? Their goal is to reap the highest reward from the least amount of effort. Litigating every case on every level; financing and staffing hundreds of complex trials, and waiting for final appellate review of every verdict is no way to run a mass tort practice ' at least not from the plaintiffs' perspective. Given this author's perspective, it makes sense to examine the options more carefully before deciding that the only way to avoid ruin is to wire massive sums into the trial bar's trust accounts.
The thoughts and observations expressed here do not come from someone with any involvement in the Vioxx litigation, and, therefore, are expressed without any particular familiarity with the facts of those individual cases or the relative strengths and weaknesses of the cases being prepared by both sides. These thoughts and observations do come from someone who has spent the last 25 years as an active participant in many of the large pharmaceutical and medical device cases that have preceded the current mass tort du jour. In every instance, with admittedly varying permutations of victory claims from both sides of the battle, the most effective answer to the onslaught of litigation has been a strong and thorough defense ' not only of the conduct and science story, but also of every individual case. Preparing the defense of these cases is never simple or inexpensive, but comprehensive preparation of every aspect of the litigation is the only effective way to overcome the inherent public prejudice and misconceptions of the pharmaceutical industry that the defendant will face as the cases proceed to trial.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
A federal district court in Miami, FL, has ruled that former National Basketball Association star Shaquille O'Neal will have to face a lawsuit over his promotion of unregistered securities in the form of cryptocurrency tokens and that he was a "seller" of these unregistered securities.
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
Blockchain domain names offer decentralized alternatives to traditional DNS-based domain names, promising enhanced security, privacy and censorship resistance. However, these benefits come with significant challenges, particularly for brand owners seeking to protect their trademarks in these new digital spaces.
In recent years, there has been a growing number of dry cleaners claiming to be "organic," "green," or "eco-friendly." While that may be true with respect to some, many dry cleaners continue to use a cleaning method involving the use of a solvent called perchloroethylene, commonly known as perc. And, there seems to be an increasing number of lawsuits stemming from environmental problems associated with historic dry cleaning operations utilizing this chemical.